American Journal of Cardiovascular Drugs

, Volume 8, Issue 4, pp 219–231

Management of Ischemic Heart Disease in Patients with Chronic Kidney Disease

Review Article

DOI: 10.2165/00129784-200808040-00002

Cite this article as:
Mutwali, A., Glynn, L.G. & Reddan, D. Am J Cardiovasc Drugs (2008) 8: 219. doi:10.2165/00129784-200808040-00002

Abstract

Patients with chronic kidney disease (CKD) and ischemic heart disease (IHD) have strikingly high mortality rates. In the general population, there has been a reduction in the mortality and morbidity rates for IHD through the implementation of effective risk-factor-reduction programs and better interventions for patients with established IHD. No such trend has been observed in patients with end-stage kidney disease.

This review article addresses the following topics: (i) epedemiology, pathogenesis, clinical CKD patients with IHD; (ii) diagnostic modalities for IHD and their limitation in CKD patients; (iii) medical treatment options and revascularization strategies for these high-risk patients; and (iv) optimal cardiovascular risk management. Generally, in CKD patients with IHD an aggressive approach to IHD is warranted, a low threshold for diagnostic testing should be employed, and awaiting a clinical trial targeting these patients they should be considered for all proven strategies to improve outcomes.

Copyright information

© Adis Data Information BV 2008

Authors and Affiliations

  1. 1.Department of Medicine, Division of NephrologyNational University of IrelandGalwayIreland
  2. 2.Department of General PracticeNational University of IrelandGalwayIreland
  3. 3.Unit 1Merlin Park University HospitalGalwayIreland